Aptose Biosciences Inc (APTO)

전일 마감가:

$1.19

열려 있는:

$1.1901

하루 거래량:

30,874

시가총액:

$19.50M

수익:

-

순이익/손실:

$-51.21M

주가수익비율:

-0.1535

EPS:

-7.82

순현금흐름:

$-44.62M

1주 성능:

-1.64%

1개월 성능:

-16.67%

6개월 성능:

-59.87%

1년 성능:

+126.84%

1일 변동 폭

$1.19

$1.23

52주 변동 폭

$0.36

$6.6001

Aptose Biosciences Inc Stock (APTO) Company Profile

명칭

Aptose Biosciences Inc

부문

Healthcare (1213)

산업

Biotechnology (699)

전화

-

주소

251 Consumers Road, Suite 1105, Toronto, ON

직원

41

트위터

다음 수익 날짜

2024-05-06

최신 SEC 제출 서류

APTO's Discussions on Twitter

Aptose Biosciences Inc Stock (APTO) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2020-10-19	개시	Cantor Fitzgerald	Overweight
2020-09-22	개시	Alliance Global Partners	Buy
2020-02-20	개시	Maxim Group	Buy
2020-02-06	재확인	H.C. Wainwright	Buy
2020-01-09	개시	Piper Sandler	Overweight
2019-03-01	개시	RBC Capital Mkts	Outperform
2018-11-16	개시	B. Riley FBR	Buy
2017-12-13	재확인	H.C. Wainwright	Buy
2017-10-23	재개	ROTH Capital	Buy
2017-09-07	업그레이드	H.C. Wainwright	Neutral → Buy
2017-06-08	개시	Rodman & Renshaw	Neutral

모두보기

Aptose Biosciences Inc 주식(APTO)의 최신 뉴스

What Makes Aptose Biosciences (APTO) a New Buy Stock

Zacks Investment Research

Aptose Reports Results for the Fourth Quarter and Full Year 2023

GlobeNewswire Inc.

Aptose to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update on Tuesday, March 26, 2024

GlobeNewswire Inc.

Assertio (ASRT) Stock Plunges 65% in 3 Months: Here's Why

Zacks Investment Research

Aptose Announces Closing of $9.7 Million Public Offering and Concurrent $4 Million Private Placement with Hanmi Pharmaceutical, Including Full Exercise of Over-Allotment Option

GlobeNewswire Inc.

Aptose Announces Pricing of $8.4 Million Public Offering and a Concurrent $4 Million Private Placement with Hanmi Pharmaceutical

GlobeNewswire Inc.

Aptose Biosciences Inc (APTO) 재무 분석

Aptose Biosciences Inc (APTO) 순이익 2024

Aptose Biosciences Inc (APTO) 현금흐름 2024

Aptose Biosciences Inc (APTO) 주당 순이익 2024